In vivo 3.0-tesla magnetic resonance T1ρ and T2 relaxation mapping in subjects with intervertebral disc degeneration and clinical symptoms

The purpose of this study is (1) to determine the correlation between T1ρ and T2 and degenerative grade in intervertebral discs using in vivo 3.0‐T MRI, and (2) to determine the association between T1ρ and T2 and clinical findings as quantified by the SF‐36 Questionnaire and Oswestry Disability Inde...

Full description

Saved in:
Bibliographic Details
Published inMagnetic resonance in medicine Vol. 63; no. 5; pp. 1193 - 1200
Main Authors Blumenkrantz, Gabrielle, Zuo, Jin, Li, Xiaojuan, Kornak, John, Link, Thomas M., Majumdar, Sharmila
Format Journal Article
LanguageEnglish
Published Hoboken Wiley Subscription Services, Inc., A Wiley Company 01.05.2010
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The purpose of this study is (1) to determine the correlation between T1ρ and T2 and degenerative grade in intervertebral discs using in vivo 3.0‐T MRI, and (2) to determine the association between T1ρ and T2 and clinical findings as quantified by the SF‐36 Questionnaire and Oswestry Disability Index. Sixteen subjects participated in this study, and each completed SF‐36 and Oswestry Disability Index questionnaires. MRI T1ρ and T2 mapping was performed to determine T1ρ (77 discs) and T2 (44 discs) in the nucleus of the intervertebral disc, and T2‐weighted images were acquired for Pfirrmann grading of disc degeneration. Pfirrmann grade was correlated with both T1ρ (r = −0.84; P < 0.01) and T2 (r = −0.61; P < 0.01). Mixed‐effects models demonstrate that only T1ρ was associated with clinical questionnaires (R2SF‐36 = 0.55, R2O.D.I. = 0.56; P < 0.05). Although the averaged values of T1ρ and T2 were significantly correlated, they presented differences in spatial distribution and dynamic range, thus suggesting different sensitivities to tissue composition. This study suggests that T1ρ may be sensitive to early degenerative changes (corroborating previous studies) and clinical symptoms in intervertebral disc degeneration. Magn Reson Med 63:1193–1200, 2010. © 2010 Wiley‐Liss, Inc.
Bibliography:NIH - No. F31 EB006708; No. R01 AG17762
istex:4DE230E8B142E7A2417CC2E42339FC3D1720DD17
ark:/67375/WNG-5GJVBW4B-7
ArticleID:MRM22362
ISSN:0740-3194
1522-2594
DOI:10.1002/mrm.22362